Maryland
To schedule your COVID immunization in MD, please click here.

 

Are you eligible?

Vaccinations are available for those ages 5 and up.
Most COVID-19 Vaccine Recipients Can Get Booster Shots

• People 12 and older should receive a booster shot at least 5 months after receiving their primary COVID-19 vaccination series. 
• People 18 years and older should receive a booster shot at least 2 months after receiving their Johnson & Johnson/Janssen COVID-19 vaccine. 

Choosing Your Covid-19 Booster Shot

Three COVID-19 vaccines are authorized or approved for use in the United States to prevent COVID-19. Pfizer-BioNTech or Moderna (COVID-19 mRNA vaccines) are preferred. You may get Johnson & Johnson's Janssen COVID-19 vaccine in some situations.

 

*Although mRNA vaccines are preferred, J&J/Janssen COVID-19 vaccine may be considered in some situations.

• Initial and booster coronavirus vaccines are available in all Weis Pharmacy locations. Click here for a list of locations.
• Pediatric vaccines for those ages 5 thru 11 are available at all locations. Click here for a list of locations. 

Note: Schedules are typically open for the next 3-4 weeks. If you need to cancel your appointment, please text us or contact your pharmacy where the appointment is scheduled.

After making your appointment, please consider either filling out the consent/background form from the link texted or by printing and completing the form located here. Bringing this completed form will facilitate your appointment.

 

Now Offering COVID Oral Therapies in select stores

Select stores now have Pfizer’s and Merck’s COVID oral therapies. These medications can be prescribed for your from a prescriber who is trained on these medications. These medications need to be started within 5 days of symptom onset and a require positive COVID test result prior to being prescribed. For more information about these medications please click here.

Participating Weis Markets Locations:

What Oral Antivirals Are Available for Treatment of COVID-19?
In the United States, there are two oral antiviral medications with emergency use authorizations (EUA) from the FDA for treatment of COVID-19. Medications need to be dispensed within 5 days of symptom onset. Please visit the webpages below for complete information about these products.

• Merck's molnupiravir 
• Pfizer's Paxlovid 

Am I Eligible to Receive Oral Antivirals?
You may be eligible for molnupiravir if you are an adult who has tested positive for COVID-19 and:

• have mild-to-moderate COVID-19 symptoms
• are at high risk for progression to severe COVID-19, including hospitalization or death, and

You may be eligible for Paxlovid if you are an adult or pediatric individual (12+ years of age and weighing at least 40 kg [88 pounds]) who has tested positive for COVID-19 and:

• have mild-to-moderate COVID-19 symptoms
• are at high risk for progression to severe COVID-19, including hospitalization or death, and

High risk reasons for more serious symptoms include:

• Age ≥ 65 years
• Obesity or being overweight based on Centers for Disease Control and Prevention clinical growth charts
• Chronic kidney disease
• Diabetes
• Immunosuppressive disease or immunosuppressive treatment
• Heart or circulatory conditions such as heart failure, coronary artery disease, cardiomyopathies, and possibly high blood pressure
• Chronic lung diseases including COPD, asthma, interstitial lung disease, cystic fibrosis, and pulmonary hypertension
• Sickle cell disease
• Neurodevelopmental disorders such as cerebral palsy
• Having a medical device

How Are Oral Antivirals Administered?
Molnupiravir is administered as 4 capsules every 12 hours for 5 days. It is important that patients complete the full 5 days of treatment with molnupiravir, even if they feel better.
Paxlovid consists of 2 medicines: nirmatrelvir and ritonavir. Patients should take 2 tablets of nirmatrelvir (150 mg) with 1 tablet of ritonavir (100 mg) by mouth twice daily (in the morning and in the evening) for 5 days. For each dose, all 3 tablets should be taken at the same time.
 
What Are the Side Effects of Oral Antivirals?
Common side effects of molnupiravir are diarrhea, nausea, and dizziness.
 
Paxlovid is contraindicated in patients with a history of clinically significant hypersensitivity reactions [e.g., toxic epidermal necrolysis (TEN) or Stevens-Johnson syndrome] to its active ingredients (nirmatrelvir or ritonavir) or any other components of the product.
Potential side effects of Paxlovid include, but are not limited to:

• Liver problems
  • Signs and symptoms of liver problems include loss of appetite, yellowing of the skin and the whites of the eyes (jaundice), dark-colored urine, pale-colored stools and itchy skin, or stomach area (abdominal) pain
• Resistance to HIV Medicines
• Altered sense of taste
• Diarrhea
• High blood pressure
• Muscle aches
   

Now Offering Drive Thru COVID-19 Tests

 

Visit a participating Weis Markets for a FREE COVID-19 test for ages 9 and up. To schedule a test and to learn more visit doineedacovid19test.com. You must schedule a test prior to arrival.

Participating Weis Markets Locations:

• 112 Atlantic Avenue, Dingmans Ferry PA
• 4525 Valley Road, Enola PA
• 5360 Lincoln Highway, Gap PA
• 6091 Westbranch Highway, Lewisburg PA
• 3440 Grandview Drive, Macungie PA
• 1272 East Penn Street, Muncy PA
• 719 Route 522, Selinsgrove PA

Curbside Weis Markets Locations:

• 9400 Scott Moore Way, Perry Hall MD